Will Next Generation Obesity Drugs make Bariatric Surgery Obsolete?
In this lively episode of Diabetes Insights, Prof. Francesco Rubino (King’s College London) and Dr. Louis Aronne (Weill Cornell Medicine) join Vivienne Parry to debate one of the biggest questions in obesity care: will next-generation medications make bariatric surgery obsolete? Drawing on decades of clinical experience and new trial evidence, they explore whether powerful GLP-1-based therapies and combination drugs can rival the life-changing outcomes of surgery. From costs and complications to patient preferences and the hidden biology of obesity, they unpack how a new era of multi-modal treatment is reshaping care. 🎧 Tune in for sharp insights, respectful disagreement and a glimpse into the future of integrated obesity management. #diabetes #Obesity #GLP1 #BariatricSurgery #Podcast